Gyre Therapeutics, Inc.
GYRE- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001124105
No open-market purchases or sales by Gyre Therapeutics, Inc. insiders were filed in the last 90 days; 59 institutions reported holding it in 13F filings for Q2 2026, worth $57.1M in total; no superinvestor holds it.
13F holders, Q4 2023
Institutional positions in Gyre Therapeutics, Inc. as of Dec 31, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 16
- −16 vs. Q3 2023
- Shares held
- 606.8K
- −1.55M (−71.8%) vs. Q3 2023
- Total value
- $15.6M
- +$14.6M (+1,404.6%) vs. Q3 2023
- New holders
- 3
- 2 more added
- Sold out
- 19
- 11 more reduced
Compare with Q3 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting GYRE on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 59 | $57.1M |
| Q1 2026 | 56 | $23.8M |
| Q4 2025 | 44 | $23.6M |
| Q3 2025 | 48 | $23.1M |
| Q2 2025 | 48 | $25.1M |
| Q1 2025 | 46 | $20.1M |
| Q4 2024 | 41 | $21.6M |
| Q3 2024 | 37 | $20.2M |
| Q2 2024 | 30 | $15.0M |
| Q1 2024 | 21 | $14.3M |
| Q4 2023 | 16 | $15.6M |
| Q3 2023 | 32 | $1.04M |
| Q2 2023 | 29 | $796.3K |
| Q1 2023 | 40 | $707.6K |
| Q4 2022 | 35 | $2.63M |
| Q3 2022 | 35 | $3.90M |
| Q2 2022 | 41 | $14.2M |
| Q1 2022 | 43 | $6.39M |
| Q4 2021 | 51 | $13.7M |
| Q3 2021 | 66 | $75.7M |
| Q2 2021 | 69 | $87.7M |
| Q1 2021 | 89 | $113.0M |
Institutions, Q4 2023
Shares, value and share of portfolio for each institution holding Gyre Therapeutics, Inc.; share changes are against Q3 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Vanguard Group Inc | 198,097 | $5.09M | 0.00% | −8,803−4.3% | Reduced |
| BlackRock Inc. | 182,157 | $4.68M | 0.00% | +28,398+18.5% | Added |
| Geode Capital Management, LLC | 134,425 | $3.45M | 0.00% | −124,321−48.0% | Reduced |
| Northern Trust Corp | 24,614 | $632.3K | 0.00% | −61,798−71.5% | Reduced |
| Parallax Volatility Advisers, L.P. | 19,901 | $511.3K | 0.01% | −23,903−54.6% | Reduced |
| Renaissance Technologies LLC | 17,085 | $439.0K | 0.00% | −573,602−97.1% | Reduced |
| State Street Corp | 14,338 | $368.3K | 0.00% | −58,261−80.3% | Reduced |
| Citigroup Inc | 7,748 | $199.0K | 0.00% | +7,748 | New |
| Qube Research & Technologies Ltd | 6,745 | $173.3K | 0.00% | +6,723+30,559.1% | Added |
| Tower Research Capital LLC (TRC) | 666 | $17.1K | 0.00% | −3,351−83.4% | Reduced |
| UBS Group AG | 333 | $8.55K | 0.00% | −4,746−93.4% | Reduced |
| JPMorgan Chase & Co | 292 | $7.50K | 0.00% | −6,760−95.9% | Reduced |
| Wetzel Investment Advisors, Inc. | 266 | $7.00K | 0.00% | +266 | New |
| Wells Fargo & Company | 94 | $2.42K | 0.00% | −107−53.2% | Reduced |
| Advisory Services Network, LLC | 66 | $1.70K | 0.00% | +66 | New |
| Advisor Group Holdings, Inc. | 14 | $360 | 0.00% | −376−96.4% | Reduced |
| Morgan Stanley | 0 | $0 | 0.00% | −97,745−100.0% | Sold out |
| Kynam Capital Management, LP | 0 | $0 | 0.00% | −90,058−100.0% | Sold out |
| Nantahala Capital Management, LLC | 0 | $0 | 0.00% | −67,800−100.0% | Sold out |
| Johnson & Johnson | 0 | $0 | 0.00% | −66,951−100.0% | Sold out |
| Acadian Asset Management LLC | 0 | $0 | 0.00% | −63,793−100.0% | Sold out |
| Barclays PLC | 0 | $0 | 0.00% | −60,204−100.0% | Sold out |
| Citadel Advisors LLC | 0 | $0 | 0.00% | −47,966−100.0% | Sold out |
| Group One Trading, L.P. | 0 | $0 | 0.00% | −46,778−100.0% | Sold out |
| Susquehanna International Group, LLP | 0 | $0 | 0.00% | −42,347−100.0% | Sold out |
| Colorado Capital Management, Inc. | 0 | $0 | 0.00% | −34,165−100.0% | Sold out |
| HSBC Holdings PLC | 0 | $0 | 0.00% | −32,528−100.0% | Sold out |
| Bank of America Corp | 0 | $0 | 0.00% | −22,484−100.0% | Sold out |
| Two Sigma Securities, LLC | 0 | $0 | 0.00% | −20,039−100.0% | Sold out |
| Raymond James & Associates | 0 | $0 | 0.00% | −12,900−100.0% | Sold out |
| Arete Wealth Advisors, LLC | 0 | $0 | 0.00% | −10,845−100.0% | Sold out |
| Cutler Group LP | 0 | $0 | 0.00% | −5,500−100.0% | Sold out |
| BNP Paribas Arbitrage, SA | 0 | $0 | 0.00% | −277−100.0% | Sold out |
| Royal Bank of Canada | 0 | $0 | 0.00% | −253−100.0% | Sold out |
| GWM Advisors LLC | 0 | $0 | 0.00% | −1−100.0% | Sold out |